Ligasure II: Standard Stapling Versus Ligasure

NCT ID: NCT01349426

Last Updated: 2015-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

172 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-09-30

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Surgical staplers have become standard for ligation, division, resection, anastomosis and closure in many surgical procedures. Staplers are utilized in thoracic surgery routinely for pulmonary parenchymal resection and closure, ligation of vessels and bronchi. In addition, closure of incomplete fissure/s is a frequent need in pulmonary surgery. Although generally safe and efficacious, staplers and staple loads are expensive, and can result in micro air leaks. The LigaSure Vessel Sealing System presents as a potentially faster and less expensive alternative to staplers. The LigaSure Vessel sealing system utilizes a combination of heat generated via bi-polar radiofrequency energy and precise jaw pressure to denature the collagen and elastin in tissue and blood vessels. The newly released Force Triad Generator and the Impact, a 10 mm jaw sealing device (Ligasure system, COVIDIEN Society) may offer improved performance in terms of tissue sticking due to an improved sealing algorithm, and to the jaw configuration of the Impact. The study main objective is to compare the quality of parenchymal pneumostasis after fissure closure achieved with staplers vs that achieved with LigaSure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Resection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LigaSure

* Arm 1
* Patients undergoing lung surgery

Group Type EXPERIMENTAL

LigaSure Force Triad Vessel Sealing System

Intervention Type DEVICE

Quality of parenchymal pneumostasis comparison after fissure closure: LigaSure vs automatic staplers

Automatic Staplers

* Arm 2
* Patients undergoing lung surgery

Group Type ACTIVE_COMPARATOR

LigaSure Force Triad Vessel Sealing System

Intervention Type DEVICE

Quality of parenchymal pneumostasis comparison after fissure closure: LigaSure vs automatic staplers

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LigaSure Force Triad Vessel Sealing System

Quality of parenchymal pneumostasis comparison after fissure closure: LigaSure vs automatic staplers

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Automatic Staplers TA30P, TA55 Endo GIA II MULTIFIRE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients older than 18 years
* Patients scheduled for thoracotomy, lobectomy or bilobectomy
* Patients must give informed consent

Exclusion Criteria

* Patient is unwilling or unable to provide informed consent
* Patients who can not tolerate thoracotomy
* Patients who require extensive dissection to release adhesions which may result in air leak and/or bleeding unrelated to the quality of the parenchymal seal achieved by the devices in question
* Patients with no parenchymal bridge between lobes; 100% complete fissure.
* Patients with complete incomplete fissure with a thickness \> 1.5 cm measure intraoperatively
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic - MITG

INDUSTRY

Sponsor Role collaborator

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

TIFFET Olivier, MD

Role: PRINCIPAL_INVESTIGATOR

CHU Sainte-Etienne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Lyon-Department of Thoracic Surgery, Cardiovascular and Chest Hospital

Bron, , France

Site Status

CHU Clermont Ferrand - Service of Thoracic Surgery

Clermont-Ferrand, , France

Site Status

CHU Grenoble - Department of Vascular and Thoracic Surgery

Grenoble, , France

Site Status

CHU Lille - Service of Thoracic Surgery

Lille, , France

Site Status

Hospital Dupuytren - Department of Thoracic and CardioVascular Surgery

Limoges, , France

Site Status

CHU Marseille - Department of Thoracic Surgery

Marseille, , France

Site Status

CHU Nice - Pasteur Hospital - Department of Thoracic Surgery

Nice, , France

Site Status

Chu Saint-Etienne

Saint-Etienne, , France

Site Status

CHU Strasbourg - Service of Thoracic Surgery

Strasbourg, , France

Site Status

Department of Thoracic Surgery, Hospital Larrey, CHU Toulouse

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-A00666-33

Identifier Type: OTHER

Identifier Source: secondary_id

1008067

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Feasibility Study of a New Fistula Pouching System
NCT00294450 COMPLETED PHASE2/PHASE3